Pharmacophore Fusion to Deliver Dual Epigenetic Modulator Active against Breast Cancer
Synfacts · 01.11.2025 · 21 (11) · 1162
DOI: 10.1055/a-2703-0840 ↗Kurz gefasst
Fachartikel in der Zeitschrift Synfacts, erschienen am 01.11.2025. Verfasst von Dirk Trauner und 1 weiteren Autor:innen. Die Arbeit nennt 1 Literaturangaben.
Abstract (Originalsprache)
Keywords epigenetics - HDAC/DNMT inhibitor - pharmacophore fusion Publication History Article published online: 30 October 2025 © 2025. Thieme. All rights reserved. Georg Thieme Verlag KG Oswald-Hesse-Straße 50, 70469 Stuttgart, Germany
Zitieren
APA
Trauner, D., & Sessions, Z. (2025). Pharmacophore Fusion to Deliver Dual Epigenetic Modulator Active against Breast Cancer. Synfacts, 21(11), 1162. https://doi.org/10.1055/a-2703-0840
Vancouver
Trauner D, Sessions Z. Pharmacophore Fusion to Deliver Dual Epigenetic Modulator Active against Breast Cancer. Synfacts. 2025;21(11):1162. doi:10.1055/a-2703-0840
BibTeX
@article{Trauner2025,
author = {Trauner, Dirk and Sessions, Zoe},
title = {Pharmacophore Fusion to Deliver Dual Epigenetic Modulator Active against Breast Cancer},
journal = {Synfacts},
year = {2025},
volume = {21},
number = {11},
pages = {1162},
doi = {10.1055/a-2703-0840}
}
EUVIMED